title: Apoptotic induction by anti-CD20 antibodies in chronic lymphocytic leukemia: comparison of rituximab and obinutuzumab.
authors.affiliation: Université Lyon , Lyon , France.
authors.forename: Lina
authors.initials: L
authors.lastname: Reslan
authors.forename: Stéphane
authors.initials: S
authors.lastname: Dalle
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Herveau
authors.forename: Emeline
authors.initials: E
authors.lastname: Perrial
authors.forename: Charles
authors.initials: C
authors.lastname: Dumontet
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000378:metabolism*; D000069283:Rituximab; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; C543332:obinutuzumab